Virginia Fernandes Moça Trevisani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Virginia Fernandes Moça Trevisani has a total of 527 co-authors. Here are the top co-authors by number of shared publications:
- Ana Carolina Pereira Nunes Pinto
Federal University of São Paulo
16 shared publications - Aline Pereira da Rocha
Programa de Pós-graduação em Saúde Baseada em Evidências, Universidade Federal de São Paulo, São Paulo, Brazil
14 shared publications - Vinicius Tassoni Civile
Programa de Pós-graduação em Saúde Baseada em Evidência, Universidade Federal de São Paulo, São Paulo, SP, Brazil
12 shared publications - César Ramos Rocha-Filho
Disciplina de Medicina de Urgência e Medicina Baseada em Evidências, Escola Paulista de Medicina – Universidade Federal de São Paulo (EPM-UNIFESP), São Paulo, Brazil
11 shared publications - Álvaro Nagib Atallah
Universidade Federal de São Paulo (Unifesp), Brazil
11 shared publications - Gabriel Sodré Ramalho
Universidade Federal de São Paulo, Brazil
8 shared publications
Latest Publications
- 21 September 2026
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2026 (9) , CD016281
Diagnostic accuracy of biological markers for detecting obstructive sleep apnoea
This is a protocol for a Cochrane review (diagnostic). The objectives are as follows: To determine the accuracy of any type of biological marker found in blood, saliva, urine or breath condensation to detect obstructive sleep apnoea (OSA) in adults (> 18 years). Secondary objectives To identify the accuracy of individual biomarkers alone or in combination for detecting OSA. To find the accuracy of biological markers compared to overnight polysomnography (PSG) and home sleep apnoea test (HSAT). To investigate the accuracy of biological markers compared to overnight PSG and to HSAT in people with different degrees of severity of OSA (mild, moderate, severe). To evaluate the accuracy of biomarkers from different sample types to identify OSA.
- 21 September 2026
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2026 (9) , CD016281
Diagnostic accuracy of biological markers for detecting obstructive sleep apnoea
This is a protocol for a Cochrane review (diagnostic). The objectives are as follows: To determine the accuracy of any type of biological marker found in blood, saliva, urine or breath condensation to detect obstructive sleep apnoea (OSA) in adults (> 18 years). Secondary objectives To identify the accuracy of individual biomarkers alone or in combination for detecting OSA. To find the accuracy of biological markers compared to overnight polysomnography (PSG) and home sleep apnoea test (HSAT). To investigate the accuracy of biological markers compared to overnight PSG and to HSAT in people with different degrees of severity of OSA (mild, moderate, severe). To evaluate the accuracy of biomarkers from different sample types to identify OSA.
- 15 July 2026
- Published by Taylor & Francis in Future Virology
- Vol. 21 (8) , 499-505
Analysis of human endogenous retrovirus K and W expression and gait parameters in patients with rheumatoid arthritis
- 15 July 2026
- Published by Taylor & Francis in Future Virology
- Vol. 21 (8) , 499-505
Analysis of human endogenous retrovirus K and W expression and gait parameters in patients with rheumatoid arthritis
- Open Access
- 1 January 2026
- Published by GN1 Sistemas e Publicacoes Ltd. in Global Academic Nursing Journal
- Vol. 7 (4) , 1-8
Cuidado centrado na pessoa hospitalizada para prevenção de quedas: protocolo de revisão de escopo
Esta revisão de escopo terá como objetivo mapear as evidências científicas sobre a implementação do cuidado centrado na pessoa na prevenção de quedas em adultos e idosos hospitalizados em ambientes clínicos. Considerando a relevância das quedas como um importante evento adverso e a necessidade de estratégias preventivas mais participativas e alinhadas às necessidades dos pacientes, esta revisão buscará compreender como o cuidado centrado na pessoa vem sendo implementado nesse contexto. Será conduzida de acordo com a metodologia do JBI e reportada conforme as recomendações do PRISMA Extension for Scoping Reviews (PRISMA-ScR). As buscas serão realizadas em bases de dados nacionais e internacionais, bem como em fontes de literatura cinzenta, sem restrição de idioma ou período de publicação. Adicionalmente, será empregada a técnica de snowballing por meio da ferramenta Citation Chaser. As fontes de evidência serão triadas no software Rayyan por dois revisores independentes, com participação de um terceiro revisor para resolução de conflitos, de acordo com os critérios de elegibilidade. A análise e a apresentação dos resultados serão realizadas por meio de síntese narrativa, organizada segundo os elementos do acrônimo PCC (População, Conceito e Contexto), utilizando recursos visuais como tabelas, quadros, gráficos, diagramas de frequência e mapas temáticos.
- 1 January 2026
- Published by GN1 Sistemas e Publicacoes Ltd. in Global Academic Nursing Journal
- Vol. 7 (4) , 1-8
Open AccessCuidado centrado na pessoa hospitalizada para prevenção de quedas: protocolo de revisão de escopo
Esta revisão de escopo terá como objetivo mapear as evidências científicas sobre a implementação do cuidado centrado na pessoa na prevenção de quedas em adultos e idosos hospitalizados em ambientes clínicos. Considerando a relevância das quedas como um importante evento adverso e a necessidade de estratégias preventivas mais participativas e alinhadas às necessidades dos pacientes, esta revisão buscará compreender como o cuidado centrado na pessoa vem sendo implementado nesse contexto. Será conduzida de acordo com a metodologia do JBI e reportada conforme as recomendações do PRISMA Extension for Scoping Reviews (PRISMA-ScR). As buscas serão realizadas em bases de dados nacionais e internacionais, bem como em fontes de literatura cinzenta, sem restrição de idioma ou período de publicação. Adicionalmente, será empregada a técnica de snowballing por meio da ferramenta Citation Chaser. As fontes de evidência serão triadas no software Rayyan por dois revisores independentes, com participação de um terceiro revisor para resolução de conflitos, de acordo com os critérios de elegibilidade. A análise e a apresentação dos resultados serão realizadas por meio de síntese narrativa, organizada segundo os elementos do acrônimo PCC (População, Conceito e Contexto), utilizando recursos visuais como tabelas, quadros, gráficos, diagramas de frequência e mapas temáticos.
- Open Access
Effects of Working from Home on Musculoskeletal Pain and Coronaphobia during the COVID-19 Pandemic
Background COVID-19 pandemic impacted the physical and mental health of Brazilian workers, especially those who started acting in home-office. Changes in the workplace, increased physical inactivity and fear of contracting the disease, known as coronophobia, may be related to increased musculoskeletal pain. Objective To analyze the prevalence of musculoskeletal pain and coronophobia in home-office workers during the COVID-19 pandemic, as well as evaluating the relationship between these variables. Method A cross-sectional, observational and descriptive study with 736 participants was conducted through online questionnaire. Sociodemographic data, working conditions, pain, besides the evaluation of coronophobia using COVID-19 Phobia scale (C19P-S) and pain with the Nordic questionnaire of osteomuscular symptoms (NMQ) were collected. Results Most participants were female (78%), with an average age of 32.8 ± 10.7 years. During the pandemic, 71% reported some osteomuscular symptoms, and of these, 64% began to have new paintings of pain in the pandemic, with higher incidence in the lower back and neck. Participants who began to perform their functions in home-office presented a higher incidence of pain and, among them, 53% reported that the furniture was not suitable for homework. Most had little fear of Covid-19, but moderate levels of coronophobia increased the chance of musculoskeletal pain (RP=1,74; IC 95%). There was a significant association between coronophobia and musculoskeletal pain. Conclusions The pandemic raised the prevalence of musculoskeletal pain, especially in cervical and lumba regions, and the fear of Covid-19 influenced this relationship.
Open AccessEffects of Working from Home on Musculoskeletal Pain and Coronaphobia during the COVID-19 Pandemic
Background COVID-19 pandemic impacted the physical and mental health of Brazilian workers, especially those who started acting in home-office. Changes in the workplace, increased physical inactivity and fear of contracting the disease, known as coronophobia, may be related to increased musculoskeletal pain. Objective To analyze the prevalence of musculoskeletal pain and coronophobia in home-office workers during the COVID-19 pandemic, as well as evaluating the relationship between these variables. Method A cross-sectional, observational and descriptive study with 736 participants was conducted through online questionnaire. Sociodemographic data, working conditions, pain, besides the evaluation of coronophobia using COVID-19 Phobia scale (C19P-S) and pain with the Nordic questionnaire of osteomuscular symptoms (NMQ) were collected. Results Most participants were female (78%), with an average age of 32.8 ± 10.7 years. During the pandemic, 71% reported some osteomuscular symptoms, and of these, 64% began to have new paintings of pain in the pandemic, with higher incidence in the lower back and neck. Participants who began to perform their functions in home-office presented a higher incidence of pain and, among them, 53% reported that the furniture was not suitable for homework. Most had little fear of Covid-19, but moderate levels of coronophobia increased the chance of musculoskeletal pain (RP=1,74; IC 95%). There was a significant association between coronophobia and musculoskeletal pain. Conclusions The pandemic raised the prevalence of musculoskeletal pain, especially in cervical and lumba regions, and the fear of Covid-19 influenced this relationship.
- Open Access
Burning mouth syndrome and micronutrient deficiency: a systematic review protocol
Introduction Burning mouth syndrome (BMS) is a complex orofacial pain disorder characterised by chronic intraoral burning or dysesthesia, typically occurring daily for more than 2 hours per day and persisting for over 3 months. The absence of identifiable causative lesions defines BMS, and symptoms may appear with or without accompanying somatosensory changes, such as altered taste or tactile sensations. This article outlines the development of a systematic review protocol to investigate the prevalence of micronutrient deficiency in patients with BMS and enhance our understanding of possible diagnoses and management of patients with this disorder. Methods and analysis This systematic review will include observational studies that assessed micronutrient levels (such as iron, folate, cobalamin, zinc and homocysteine) to identify which micronutrients are lower than the normal range in patients with BMS. A literature search will be conducted on 25 August 2025, using the following databases: MEDLINE, Embase, LILACS, Scopus, Web of Science and the grey literature. Key terms such as “Burning Mouth Syndrome”, “stomatodynia”, “glossopyrosis”, “micronutrients” and “vitamins” will be used in our search strategies. Experts in the topic and reference lists of included studies will also be consulted. Two independent reviewers will select the study using a two-phase process. Data collection will be performed by one author and cross-checked by another. The risk of bias assessment will be conducted following the JBI tool. Meta-analyses may be performed to analyse the proportion of patients with micronutrient deficiency for each micronutrient investigated. Ethics and dissemination This systematic review does not require ethical approval. On completion, it will be published in a peer-reviewed academic journal and presented at a conference. PROSPERO registration number CRD42024626960.
Open AccessBurning mouth syndrome and micronutrient deficiency: a systematic review protocol
Introduction Burning mouth syndrome (BMS) is a complex orofacial pain disorder characterised by chronic intraoral burning or dysesthesia, typically occurring daily for more than 2 hours per day and persisting for over 3 months. The absence of identifiable causative lesions defines BMS, and symptoms may appear with or without accompanying somatosensory changes, such as altered taste or tactile sensations. This article outlines the development of a systematic review protocol to investigate the prevalence of micronutrient deficiency in patients with BMS and enhance our understanding of possible diagnoses and management of patients with this disorder. Methods and analysis This systematic review will include observational studies that assessed micronutrient levels (such as iron, folate, cobalamin, zinc and homocysteine) to identify which micronutrients are lower than the normal range in patients with BMS. A literature search will be conducted on 25 August 2025, using the following databases: MEDLINE, Embase, LILACS, Scopus, Web of Science and the grey literature. Key terms such as “Burning Mouth Syndrome”, “stomatodynia”, “glossopyrosis”, “micronutrients” and “vitamins” will be used in our search strategies. Experts in the topic and reference lists of included studies will also be consulted. Two independent reviewers will select the study using a two-phase process. Data collection will be performed by one author and cross-checked by another. The risk of bias assessment will be conducted following the JBI tool. Meta-analyses may be performed to analyse the proportion of patients with micronutrient deficiency for each micronutrient investigated. Ethics and dissemination This systematic review does not require ethical approval. On completion, it will be published in a peer-reviewed academic journal and presented at a conference. PROSPERO registration number CRD42024626960.
- Open Access
- 20 August 2025
- Published by Springer Nature in Advances in Rheumatology
- Vol. 65 (1) , 1-8
Prevalence of solid tumors and lymphoma in the Brazilian Sjögren’s Disease Registry (BRAS): an important concern for clinical practice
Background: About 5–10% of patients with Sjögren’s Disease (SjD) will develop non-Hodgkin’s lymphoma, with a 16 to 44 increased risk compared to the general population. The relationship between SjD and other types of cancer is poorly described in the literature. Aim: To characterize patients with SjD from the Brazilian Sjögren’s Disease Registry (BRAS) who developed hematological and solid neoplasms, analyzing the organ primarily involved, subtypes, occurrence of metastatic disease, timing of diagnosis and correlation with demographic, serologic aspects, and labial salivary gland inflammation. Methods: Among consecutive patients included in the Brazilian Sjögren’s Disease Registry (BRAS) and fulfilling the 2002 or 2016 classification criteria for SjD, those who developed neoplasia were retrospectively identified and categorized according to the National Cancer Institute (Ministry of Health, Brazil). RESULTS: 1,010 patients were included; of them, 975 were women (96.5%), with an average age of 55.6 ± 13.6 years. Disease duration was 11.9 ± 7.9 years. We found that 114 out of 1,010 patients (11.3%) had cancer, with a higher prevalence in those over 55 years old ( p < 0.001). The most prevalent malignancies were skin cancer [24/858 (2.7%)], breast cancer [27/1010 (2.6%)], lymphoma [15/1010 (1.5%)], and thyroid cancer [8/1010 (0.8%)]. Further, 0.9% of patients had more than one type of cancer. Cancer diagnosis followed SjD diagnosis in 66.7% of lymphoma cases, 53.6% of other malignancies, and 75.0% of skin cancer. The presence of cancer was associated with age (OR 1.04). In the case of skin cancer, the duration of SjD was an additional risk factor (OR 1.08). For thyroid cancer, inflammation of the labial minor salivary glands was identified as an associated risk factor (OR 10.1). Conclusions: Other types of cancer were more prevalent than lymphoma in our population of SjD patients. Breast neoplasia emerged as the most prevalent after skin cancer, and thyroid cancer was the second most prevalent solid neoplasia. Aging, disease duration and labial salivary gland inflammation were associated risk factors. Prospective cohort studies are essential for assessing other risk factors for cancer development in SjD patients.
- 20 August 2025
- Published by Springer Nature in Advances in Rheumatology
- Vol. 65 (1) , 1-8
Open AccessPrevalence of solid tumors and lymphoma in the Brazilian Sjögren’s Disease Registry (BRAS): an important concern for clinical practice
Background: About 5–10% of patients with Sjögren’s Disease (SjD) will develop non-Hodgkin’s lymphoma, with a 16 to 44 increased risk compared to the general population. The relationship between SjD and other types of cancer is poorly described in the literature. Aim: To characterize patients with SjD from the Brazilian Sjögren’s Disease Registry (BRAS) who developed hematological and solid neoplasms, analyzing the organ primarily involved, subtypes, occurrence of metastatic disease, timing of diagnosis and correlation with demographic, serologic aspects, and labial salivary gland inflammation. Methods: Among consecutive patients included in the Brazilian Sjögren’s Disease Registry (BRAS) and fulfilling the 2002 or 2016 classification criteria for SjD, those who developed neoplasia were retrospectively identified and categorized according to the National Cancer Institute (Ministry of Health, Brazil). RESULTS: 1,010 patients were included; of them, 975 were women (96.5%), with an average age of 55.6 ± 13.6 years. Disease duration was 11.9 ± 7.9 years. We found that 114 out of 1,010 patients (11.3%) had cancer, with a higher prevalence in those over 55 years old ( p < 0.001). The most prevalent malignancies were skin cancer [24/858 (2.7%)], breast cancer [27/1010 (2.6%)], lymphoma [15/1010 (1.5%)], and thyroid cancer [8/1010 (0.8%)]. Further, 0.9% of patients had more than one type of cancer. Cancer diagnosis followed SjD diagnosis in 66.7% of lymphoma cases, 53.6% of other malignancies, and 75.0% of skin cancer. The presence of cancer was associated with age (OR 1.04). In the case of skin cancer, the duration of SjD was an additional risk factor (OR 1.08). For thyroid cancer, inflammation of the labial minor salivary glands was identified as an associated risk factor (OR 10.1). Conclusions: Other types of cancer were more prevalent than lymphoma in our population of SjD patients. Breast neoplasia emerged as the most prevalent after skin cancer, and thyroid cancer was the second most prevalent solid neoplasia. Aging, disease duration and labial salivary gland inflammation were associated risk factors. Prospective cohort studies are essential for assessing other risk factors for cancer development in SjD patients.
- Open Access
- 15 August 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (8) , 1276
Risk Factors for Locomotive Syndrome in Brazilian Older Adults: A Nested Case–Control Study
This study aimed to describe the risk factors for locomotive syndrome (LS) in Brazilian oldest old individuals. Study subjects were older adults aged ≥80 years who were cognitively healthy, independent for activities of daily living and had been followed since 2011 by a Brazilian cohort study entitled the Longevos Project. A nested case–control study evaluating demographic and clinical characteristics was conducted. Physical tests including the 5 times sit-to-stand, hand-grip strength, 4-m gait speed and two-step test were performed. The World Health Organization Quality of Life Questionnaire short form (WHOQOL-BREF) and Numerical Rating Scale plus Verbal Rating Scale were applied to assess quality of life (QOL) and chronic pain (CP), respectively. LS was diagnosed using the Brazilian version of the 25-question Geriatric Locomotive Function Scale (GLFS-25-p), and sarcopenia by the SARC-F screening tool. The study sample included 52 participants, had a mean age of 89.3 years (±3.9 years) and was predominantly female (76.9%). Of this sample, 24 were diagnosed with LS and 28 were not. The prevalence of osteoporosis (20%), osteoarthritis (22%), depression (13%) and use of a walking device (14%) was higher in the LS group. Participants with LS had worse performance in physical tests. A multivariate logistic regression analysis identified the main risk factors for LS as osteoporosis (OR 10.80, 95%CI 1.08–108.48) and presence of moderate-to-severe chronic musculoskeletal pain (OR 8.92, 95%CI 1.25–63.89).
- 15 August 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (8) , 1276
Open AccessRisk Factors for Locomotive Syndrome in Brazilian Older Adults: A Nested Case–Control Study
This study aimed to describe the risk factors for locomotive syndrome (LS) in Brazilian oldest old individuals. Study subjects were older adults aged ≥80 years who were cognitively healthy, independent for activities of daily living and had been followed since 2011 by a Brazilian cohort study entitled the Longevos Project. A nested case–control study evaluating demographic and clinical characteristics was conducted. Physical tests including the 5 times sit-to-stand, hand-grip strength, 4-m gait speed and two-step test were performed. The World Health Organization Quality of Life Questionnaire short form (WHOQOL-BREF) and Numerical Rating Scale plus Verbal Rating Scale were applied to assess quality of life (QOL) and chronic pain (CP), respectively. LS was diagnosed using the Brazilian version of the 25-question Geriatric Locomotive Function Scale (GLFS-25-p), and sarcopenia by the SARC-F screening tool. The study sample included 52 participants, had a mean age of 89.3 years (±3.9 years) and was predominantly female (76.9%). Of this sample, 24 were diagnosed with LS and 28 were not. The prevalence of osteoporosis (20%), osteoarthritis (22%), depression (13%) and use of a walking device (14%) was higher in the LS group. Participants with LS had worse performance in physical tests. A multivariate logistic regression analysis identified the main risk factors for LS as osteoporosis (OR 10.80, 95%CI 1.08–108.48) and presence of moderate-to-severe chronic musculoskeletal pain (OR 8.92, 95%CI 1.25–63.89).
- 28 July 2025
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology
Two-dimentional shear wave elastography as an alternative method of ultrasound for major salivary glands evaluation in Sjögren's disease
This study aimed to investigate the performance of 2-dimensional shear wave elastography (2D-SWE) in the assessment of major salivary glands (MSG) involvement in patients with Sjögren's Disease (SjD), compared with B-mode ultrasound (B-mode US), both individually and in combination, and to evaluate the association between elastography parameters and clinical and laboratory data. This cross-sectional study included 52 patients with SjD and 48 age, sex and ethnicity-matched healthy controls. Clinical and laboratory characteristics of the patients were recorded. MSG were assessed by B-mode US, and 2D-SWE, in both parameters [elasticity and shear wave velocity (SWV)]. B-mode US and SWE parameters revealed significant differences between patients with SjD and healthy controls. Analysis of the four MSG combined demonstrated that SjD patients had higher values of elasticity (15.2±2.9 vs. 9.3±0.8 kPa; p<0.001) and SWV (2.2±0.2 vs. 1.8±0.1m/s; p<0.001) compared with controls. Both elasticity and SWV showed excellent diagnostic performance for SjD (AUC=0.982 and 0.983, respectively). Comparatively, the elastography parameters showed higher AUCs than B-mode US (AUC=0.852). Combining both methods provided superior predictive ability (AUC=0.985) compared to isolated use of B-mode US. No significant correlations were observed between SWE parameters and clinical or laboratory features, except for the glandular domain of the ESSDAI (r=0.286; p=0.040). Elastography seems to be a promising tool for providing additional diagnostic value in SjD. 2D-SWE, either alone or in combination with B-mode US, may contribute to the assessment of MSG as a quantitative, non-invasive and feasible imaging method. However, further studies are needed to validate this technique.
- 28 July 2025
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology
Two-dimentional shear wave elastography as an alternative method of ultrasound for major salivary glands evaluation in Sjögren's disease
This study aimed to investigate the performance of 2-dimensional shear wave elastography (2D-SWE) in the assessment of major salivary glands (MSG) involvement in patients with Sjögren's Disease (SjD), compared with B-mode ultrasound (B-mode US), both individually and in combination, and to evaluate the association between elastography parameters and clinical and laboratory data. This cross-sectional study included 52 patients with SjD and 48 age, sex and ethnicity-matched healthy controls. Clinical and laboratory characteristics of the patients were recorded. MSG were assessed by B-mode US, and 2D-SWE, in both parameters [elasticity and shear wave velocity (SWV)]. B-mode US and SWE parameters revealed significant differences between patients with SjD and healthy controls. Analysis of the four MSG combined demonstrated that SjD patients had higher values of elasticity (15.2±2.9 vs. 9.3±0.8 kPa; p<0.001) and SWV (2.2±0.2 vs. 1.8±0.1m/s; p<0.001) compared with controls. Both elasticity and SWV showed excellent diagnostic performance for SjD (AUC=0.982 and 0.983, respectively). Comparatively, the elastography parameters showed higher AUCs than B-mode US (AUC=0.852). Combining both methods provided superior predictive ability (AUC=0.985) compared to isolated use of B-mode US. No significant correlations were observed between SWE parameters and clinical or laboratory features, except for the glandular domain of the ESSDAI (r=0.286; p=0.040). Elastography seems to be a promising tool for providing additional diagnostic value in SjD. 2D-SWE, either alone or in combination with B-mode US, may contribute to the assessment of MSG as a quantitative, non-invasive and feasible imaging method. However, further studies are needed to validate this technique.
- Open Access
- 11 February 2025
- Published by Springer Nature in Advances in Rheumatology
- Vol. 65 (1) , 1-16
Recommendations on neurologic, cognitive, and psychiatric manifestations in patients with Sjögren’s disease by the Brazilian Society of Rheumatology
Background: Neurological and psychiatric manifestations occur in patients with primary Sjogren’s disease (SjD) with a wide-ranging clinical presentation, affecting quality of life, social participation, and prognosis. Despite this, neither central nor peripheral neurological symptoms are systematically evaluated in the context of autoimmunity or identified as manifestations of SjD. The EULAR Sjogren’s Syndrome Disease Activity Index (ESSDAI) covers only part of them in the neurological domain. Methods: We performed a systematic review of the diagnosis and prevalence of central, peripheral, and autonomic nervous system manifestations in primary SjD, following the recommendations proposed by the Cochrane Collaboration Handbook. Observational studies were included when their main issue was the diagnosis and the prevalence of the manifestations individually. We employed a generalized linear mixed model (GLMM) method with a random-effects model, and the results were computed using logit transformation, implemented through the ‘meta’ and ‘metafor’ packages in the R software (version 3.6.1). To present these recommendations, agreement among experts was investigated using the Delphi method in in-person meetings. Results: We propose ten recommendations regarding the investigation and management of neurological involvement in SjD that had 100% agreement among participants. Conclusion: These recommendations add to the literature on the clinical care of patients with SjD.
- 11 February 2025
- Published by Springer Nature in Advances in Rheumatology
- Vol. 65 (1) , 1-16
Open AccessRecommendations on neurologic, cognitive, and psychiatric manifestations in patients with Sjögren’s disease by the Brazilian Society of Rheumatology
Background: Neurological and psychiatric manifestations occur in patients with primary Sjogren’s disease (SjD) with a wide-ranging clinical presentation, affecting quality of life, social participation, and prognosis. Despite this, neither central nor peripheral neurological symptoms are systematically evaluated in the context of autoimmunity or identified as manifestations of SjD. The EULAR Sjogren’s Syndrome Disease Activity Index (ESSDAI) covers only part of them in the neurological domain. Methods: We performed a systematic review of the diagnosis and prevalence of central, peripheral, and autonomic nervous system manifestations in primary SjD, following the recommendations proposed by the Cochrane Collaboration Handbook. Observational studies were included when their main issue was the diagnosis and the prevalence of the manifestations individually. We employed a generalized linear mixed model (GLMM) method with a random-effects model, and the results were computed using logit transformation, implemented through the ‘meta’ and ‘metafor’ packages in the R software (version 3.6.1). To present these recommendations, agreement among experts was investigated using the Delphi method in in-person meetings. Results: We propose ten recommendations regarding the investigation and management of neurological involvement in SjD that had 100% agreement among participants. Conclusion: These recommendations add to the literature on the clinical care of patients with SjD.
- 28 January 2025
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 52 (4) , 540-553
Effects of Photobiomodulation on Burning Mouth Syndrome: A Systematic Review and Meta‐Analysis
Objective: The objective of this research is to evaluate the effectiveness and safety of photobiomodulation or low‐level laser therapy on burning mouth syndrome compared to placebo, no‐laser, clonazepam and alpha‐lipoic acid.Methods: A systematic review of randomised clinical trials was performed. The databases consulted were MEDLINE, CENTRAL, LILACS, EMBASE and clinical trial registries ClincalTrial.org and WHO‐ICTRP, to retrieve citations published until April 4, 2023. In addition, we consulted the grey literature for unpublished studies. There were no restrictions on language, publication status and publication date. Outcomes included pain relief, change in oral health quality of life, adverse effects and change in the quality of life concerning anxiety and depression. Two independent authors performed the study selection, and the risk of bias was assessed using the Cochrane collaboration tool. The random effect was calculated with a 95% confidence interval to calculate the relative risk. We performed heterogeneity by I2 and subgroup analysis. For all calculations, we used Review Manager 5.4.1 software.Results: In total, 528 references were located, and 13 studies were included, with 503 participants. Seven studies were evaluated qualitatively, and six were grouped for data meta‐analysis according to the type of laser used, red or infrared. The following comparisons were evaluated: laser versus placebo, laser versus clonazepam and laser versus alpha‐lipoic acid. Less pain was reported with the use of a laser, with low quality of evidence, in the comparisons: red laser versus placebo with a weighted mean difference (WMD) of −1.18; 95% CI [−2.16 to −0.19]; I2 = 61%; N = 58; 2 RCTs; infrared laser versus placebo with WMD = −1.34; 95% CI [−1.86 to −0.82]; I2 = 14%; N = 87; 3 RCTs; laser versus clonazepam with mean difference (MD) of −1.66; 95% CI [−3.17 to −0.15]; I2 = 0%; N = 33; 1 RCT. Oral health quality of life was better with the use of the laser, with very low quality of evidence, in the comparisons: red laser versus placebo with WMD = −1.08; 95% CI [−1.49 to −0.66]; I2 = 0%; N = 105; 2 RCTs; infrared laser versus placebo with WMD = −0.46; 95% CI [−1.70 to 0.78]; I2 = 86%; N = 85; 3 RCTs; laser versus clonazepam with MD = −19.65; 95% CI [−45.97 to 6.67]; N = 33; 1 RCT. For anxiety and depression, there was no significant difference between the groups, with very low quality of evidence, in the comparisons: infrared laser versus placebo, for anxiety with MD = 0.11; 95% CI [−2.64 to 2.86]; N = 28; 1 RCT; and for depression with MD = −0.66; 95% CI [−3.56 to 3.44]; N = 28; 1 RCT. Likewise, the comparison of laser versus clonazepam for anxiety and depression with MD = 1.05; 95% CI [−2.83 to 4.93]; N = 33; 1 RCT.Conclusion: Pain was less common, and quality of life was better when using a low‐level laser than placebo and clonazepam. The certainty of the evidence obtained was low and very low, respectively, meaning that the true effect may differ substantially from the effect estimate. Further well‐conducted RCTs are needed to increase the degree of certainty of the evidence obtained.
- 28 January 2025
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 52 (4) , 540-553
Effects of Photobiomodulation on Burning Mouth Syndrome: A Systematic Review and Meta‐Analysis
Objective: The objective of this research is to evaluate the effectiveness and safety of photobiomodulation or low‐level laser therapy on burning mouth syndrome compared to placebo, no‐laser, clonazepam and alpha‐lipoic acid.Methods: A systematic review of randomised clinical trials was performed. The databases consulted were MEDLINE, CENTRAL, LILACS, EMBASE and clinical trial registries ClincalTrial.org and WHO‐ICTRP, to retrieve citations published until April 4, 2023. In addition, we consulted the grey literature for unpublished studies. There were no restrictions on language, publication status and publication date. Outcomes included pain relief, change in oral health quality of life, adverse effects and change in the quality of life concerning anxiety and depression. Two independent authors performed the study selection, and the risk of bias was assessed using the Cochrane collaboration tool. The random effect was calculated with a 95% confidence interval to calculate the relative risk. We performed heterogeneity by I2 and subgroup analysis. For all calculations, we used Review Manager 5.4.1 software.Results: In total, 528 references were located, and 13 studies were included, with 503 participants. Seven studies were evaluated qualitatively, and six were grouped for data meta‐analysis according to the type of laser used, red or infrared. The following comparisons were evaluated: laser versus placebo, laser versus clonazepam and laser versus alpha‐lipoic acid. Less pain was reported with the use of a laser, with low quality of evidence, in the comparisons: red laser versus placebo with a weighted mean difference (WMD) of −1.18; 95% CI [−2.16 to −0.19]; I2 = 61%; N = 58; 2 RCTs; infrared laser versus placebo with WMD = −1.34; 95% CI [−1.86 to −0.82]; I2 = 14%; N = 87; 3 RCTs; laser versus clonazepam with mean difference (MD) of −1.66; 95% CI [−3.17 to −0.15]; I2 = 0%; N = 33; 1 RCT. Oral health quality of life was better with the use of the laser, with very low quality of evidence, in the comparisons: red laser versus placebo with WMD = −1.08; 95% CI [−1.49 to −0.66]; I2 = 0%; N = 105; 2 RCTs; infrared laser versus placebo with WMD = −0.46; 95% CI [−1.70 to 0.78]; I2 = 86%; N = 85; 3 RCTs; laser versus clonazepam with MD = −19.65; 95% CI [−45.97 to 6.67]; N = 33; 1 RCT. For anxiety and depression, there was no significant difference between the groups, with very low quality of evidence, in the comparisons: infrared laser versus placebo, for anxiety with MD = 0.11; 95% CI [−2.64 to 2.86]; N = 28; 1 RCT; and for depression with MD = −0.66; 95% CI [−3.56 to 3.44]; N = 28; 1 RCT. Likewise, the comparison of laser versus clonazepam for anxiety and depression with MD = 1.05; 95% CI [−2.83 to 4.93]; N = 33; 1 RCT.Conclusion: Pain was less common, and quality of life was better when using a low‐level laser than placebo and clonazepam. The certainty of the evidence obtained was low and very low, respectively, meaning that the true effect may differ substantially from the effect estimate. Further well‐conducted RCTs are needed to increase the degree of certainty of the evidence obtained.